Urh Grošelj

3.3k total citations
92 papers, 943 citations indexed

About

Urh Grošelj is a scholar working on Clinical Biochemistry, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Urh Grošelj has authored 92 papers receiving a total of 943 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Clinical Biochemistry, 23 papers in Surgery and 21 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Urh Grošelj's work include Metabolism and Genetic Disorders (27 papers), Lipoproteins and Cardiovascular Health (20 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (11 papers). Urh Grošelj is often cited by papers focused on Metabolism and Genetic Disorders (27 papers), Lipoproteins and Cardiovascular Health (20 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (11 papers). Urh Grošelj collaborates with scholars based in Slovenia, Germany and United States. Urh Grošelj's co-authors include Tadej Battelino, Jernej Kovač, Katarina Trebušak Podkrajšek, Mojca Žerjav Tanšek, Barbka Repič Lampret, Matej Mlinarič, Nataša Bratina, Nevenka Bratanič, Maruša Debeljak and Albert Wiegman and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.

In The Last Decade

Urh Grošelj

81 papers receiving 912 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Urh Grošelj Slovenia 16 313 248 204 198 165 92 943
Piers R. Blackett United States 20 196 0.6× 85 0.3× 354 1.7× 501 2.5× 320 1.9× 59 1.2k
Konrad Szymañski Poland 18 180 0.6× 36 0.1× 182 0.9× 153 0.8× 103 0.6× 44 1.3k
Eva Feigerlová France 18 175 0.6× 39 0.2× 257 1.3× 224 1.1× 316 1.9× 57 956
Xiaomu Kong China 15 157 0.5× 28 0.1× 240 1.2× 171 0.9× 102 0.6× 42 717
Yusaku Tazawa Japan 17 407 1.3× 444 1.8× 176 0.9× 144 0.7× 74 0.4× 63 1.2k
Ron S. Newfield United States 20 208 0.7× 34 0.1× 278 1.4× 539 2.7× 222 1.3× 61 1.3k
O Søvik Norway 17 486 1.6× 94 0.4× 277 1.4× 606 3.1× 463 2.8× 58 1.1k
Edith Lerner United States 17 54 0.2× 192 0.8× 404 2.0× 103 0.5× 71 0.4× 24 1.3k
Ikuma Fujiwara Japan 20 96 0.3× 37 0.1× 352 1.7× 260 1.3× 173 1.0× 66 1.0k
Min Nie China 22 150 0.5× 27 0.1× 587 2.9× 469 2.4× 453 2.7× 130 1.6k

Countries citing papers authored by Urh Grošelj

Since Specialization
Citations

This map shows the geographic impact of Urh Grošelj's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Urh Grošelj with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Urh Grošelj more than expected).

Fields of papers citing papers by Urh Grošelj

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Urh Grošelj. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Urh Grošelj. The network helps show where Urh Grošelj may publish in the future.

Co-authorship network of co-authors of Urh Grošelj

This figure shows the co-authorship network connecting the top 25 collaborators of Urh Grošelj. A scholar is included among the top collaborators of Urh Grošelj based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Urh Grošelj. Urh Grošelj is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Grošelj, Urh. (2025). Newborn screening for rare diseases: expanding the paradigm in the genomic era. Journal of Perinatal Medicine. 54(1). 116–122.
3.
Schielen, Peter C. J. I., Rolf Zetterström, Maurizio Scarpa, et al.. (2025). International Survey on Phenylketonuria Newborn Screening. International Journal of Neonatal Screening. 11(1). 18–18.
4.
Grošelj, Urh, Riittakerttu Kaltiala‐Heino, Robert Vermeiren, et al.. (2024). ESCAP statement on the care for children and adolescents with gender dysphoria: an urgent need for safeguarding clinical, scientific, and ethical standards. European Child & Adolescent Psychiatry. 33(6). 2011–2016. 15 indexed citations
5.
Kovač, Jernej, et al.. (2024). PRESEJALNO TESTIRANJE NOVOROJENČKOV ZA VROJENE BOLEZNI V SLOVENIJI. SHILAP Revista de lepidopterología. 31(2). 77–84. 1 indexed citations
6.
Dolžan, Vita, Mojca Žerjav Tanšek, Andrea Pastorakova, et al.. (2023). Genetic and clinical characteristics including occurrence of testicular adrenal rest tumors in Slovak and Slovenian patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Frontiers in Endocrinology. 14. 1134133–1134133. 5 indexed citations
7.
Šuštar, Urša, et al.. (2023). Evaluation of Body Mass Index, Overweight and Obesity Status, and Cholesterol Levels in Younger Children. JAMA Network Open. 6(4). e238141–e238141. 3 indexed citations
8.
9.
Mlinarič, Matej, James R. Bonham, Viktor Kožich, et al.. (2023). Newborn Screening in a Pandemic—Lessons Learned. International Journal of Neonatal Screening. 9(2). 21–21. 1 indexed citations
10.
Gidding, Samuel S., Albert Wiegman, Urh Grošelj, et al.. (2022). Paediatric familial hypercholesterolaemia screening in Europe: public policy background and recommendations. European Journal of Preventive Cardiology. 29(18). 2301–2311. 40 indexed citations
11.
Šuštar, Urša, Olga Kordonouri, Matej Mlinarič, et al.. (2022). Universal screening for familial hypercholesterolemia in 2 populations. Genetics in Medicine. 24(10). 2103–2111. 23 indexed citations
12.
Grošelj, Urh, Nataša Bratina, Maruša Debeljak, et al.. (2021). Two Cases With an Early Presented Proopiomelanocortin Deficiency—A Long-Term Follow-Up and Systematic Literature Review. Frontiers in Endocrinology. 12. 689387–689387. 25 indexed citations
13.
Mlinarič, Matej, et al.. (2020). Case Report: Liver Transplantation in Homozygous Familial Hypercholesterolemia (HoFH)—Long-Term Follow-Up of a Patient and Literature Review. Frontiers in Pediatrics. 8. 567895–567895. 14 indexed citations
14.
Battelino, Tadej, et al.. (2019). Development of a pilot rare disease registry: a focus group study of initial steps towards the establishment of a rare disease ecosystem in Slovenia. Orphanet Journal of Rare Diseases. 14(1). 172–172. 17 indexed citations
15.
Grošelj, Urh, Jernej Kovač, Urša Šuštar, et al.. (2018). Universal screening for familial hypercholesterolemia in children: The Slovenian model and literature review. Atherosclerosis. 277. 383–391. 70 indexed citations
16.
Grošelj, Urh, et al.. (2017). End-of-life decisions in 34 Slovene Intensive Care Units: a nationwide prospective clinical study. Minerva Anestesiologica. 83(7). 728–736. 4 indexed citations
17.
Grosek, Štefan, et al.. (2013). Etične dileme ob koncu življenja v intenzivni medicini. Slovenian Medical Journal. 82(9). 1 indexed citations
18.
Grosek, Štefan, et al.. (2013). End-of-life ethical dilemmas in intensive care unit.. SHILAP Revista de lepidopterología. 82(9). 589–601. 1 indexed citations
19.
Grošelj, Urh, Mojca Žerjav Tanšek, Katarina Trebušak Podkrajšek, & Tadej Battelino. (2013). Genetic and clinical characteristics of patients with phenylketonuria in Slovenia. SHILAP Revista de lepidopterología. 3 indexed citations
20.
Grošelj, Urh, et al.. (2006). Abstract 11: Is Therapeutic Hypothermia After Cardiac Arrest Harmful For Diabetic Patients?. Circulation. 114. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026